Phone: +44 141 899 0081

Archive

Home / Tag: Clinical Trials

Want to know more about our PRIME & EAMS / PIM experience? Meet us at the 2017 DIA EuroMeeting in Glasgow, 29 – 31 March 2017

With the increasing acknowledgement of the need to develop an overarching scheme to enhance support for sponsors developing medicines, tackling unmet medical needs to ensure timely access to beneficial therapies, the EMA launched the PRIME scheme in March 2016. This

ASH, SABCS, IASLC WCLC Highlights

ASH 2016 Highlights, December 3-6 2016AbbVie Inc. & Janssen – Ibrutinib (IMBRUVICA®). PCYC-1121-CA Phase II trial assessed ibrutinib as a single-agent treatment for marginal zone lymphoma patients that received one or more prior therapies including at least one CD20-directed regimen. In the study, 79% of